Further analysis is needed, but it is possible that FC at 500 mg/day is sufficient to improve the anemic state in patients with mild anemia whose Hb concentration is around 10.0 g/dL; this dosage of FC may also improve patients’ adherence because of its easy dose regimen (two tablets once daily). The gene discussed is GSTM1; the disease is anemia.